Country: Малезија
Језик: Енглески
Извор: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
MERCK SDN. BHD.
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
100 Tablets; 30 Tablets; 90 Tablets; 50 Tablets; 60 Tablets
Merck Healthcare KGaA
Consumer Medication Information Leaflet (RiMUP) 1 LODOZ TABLET Lodoz 2.5 mg / 6.25 mg:2.5 mg bisoprolol fumarate & 6.25 mg hydrochlorothiazide Lodoz 5 mg / 6.25 mg:5 mg bisoprolol fumarate & 6.25 mg hydrochlorothiazide What is in this leaflet 1. What Lodoz is used for 2. How Lodoz works 3. Before you use Lodoz 4. How to take Lodoz 5. While you are using Lodoz 6. Side Effects 7. Storage and Disposal of Lodoz 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision 11. Serial number What Lodoz is used for The active substances are bisoprolol and hydrochlorothiazide. This medicine is recommended in the treatment of high blood pressure in patients whose blood pressure is not sufficiently controlled by bisoprolol or hydrochlorothiazide alone. How does Lodoz works Bisoprolol belongs to the family of medicines called beta-blockers and it is used to decrease blood pressure. Bisoprolol slows down the heart rate and makes the heart more efficient at pumping blood around the body Hydrochlorothiazide belongs to the family of medicines called thiazide diuretics (also known as “water tablets”). Hydrochlorothiazide helps to lower blood pressure by increasing the elimination of urine. Before you take Lodoz - When you must not take it If you, are allergic to bisoprolol, hydrochlorothiazide, other thiazides, sulphonamides (substances chemically related to hydrochlorothiazide) or any of the other ingredients of this medicine. suffer from acute weakness of the heart muscle (acute heart failure) or if your heart muscle weakness is not under control (decompensated heart failure) suffer from shock due to a heart attack (cardiogenic shock) have major disturbances of heart rhythm (2nd and 3rd degree AV block, sick sinus syndrome, sino- atrial block) have a severely slowed heart rate suffer from severe forms of asthma or any other breathing problems such as chronic respiratory disorders have severe circulatory disorders affecting the limbs (such as Raynaud’s syndrome tha Прочитајте комплетан документ
Lodoz® 2.5 mg/6.25 mg, film-coated tablet Lodoz® 5 mg/6.25 mg, film-coated tablet Bisoprolol fumarate Hydrochlorothiazide QUALITATIVE AND QUANTITATIVE COMPOSITION Lodoz 2.5 mg/6.25 mg, film-coated tablet: Bisoprolol fumarate 2.5 mg Hydrochlorothiazide 6.25 mg Lodoz 5 mg/6.25 mg, film-coated tablet: Bisoprolol fumarate 5 mg Hydrochlorothiazide 6.25 mg PHARMACEUTICAL FORM Lodoz 2.5 mg/6.25 mg, film-coated tablet: Film coated tablet Yellow, round, biconvex upper side embossed heart, downside embossed 2.5. Lodoz 5 mg/6.25 mg, film-coated tablet: Film coated tablet Pastel-pink, round, biconvex, upper side embossed heart, downside embossed 5. ROUTE OF ADMINISTRATION Oral CLINICAL PARTICULARS Therapeutic indications Mild to moderate hypertension. Posology and method of administration For individual therapy Lodoz is available in the strengths: Lodoz 2.5/6.25 mg, film-coated tablets Lodoz 5/6.25 mg, film-coated tablets The initial dosage is one tablet containing bisoprolol 2.5 mg + hydrochlorothiazide 6.25 mg once daily. If inadequate response to treatment is obtained, the dosage should be increased to one tablet containing bisoprolol 5 mg + hydrochlorothiazide 6.25 mg in a once daily dose. If latter proves to be insufficiently effective, the dosage may be increased to bisoprolol 10 mg + hydrochlorothiazide 6.25 mg once daily. If discontinuation is necessary, gradual discontinuation of bisoprolol treatment is recommended, since abrupt withdrawal of bisoprolol may lead to an acute deterioration of the patient‘s condition, in particular in patients with ischaemic heart disease. Lodoz should be swallowed in the morning and can be taken with food. The film-coated tablets should be swallowed with some liquid and not be chewed. No dose adjustment is necessary in patients with mild-to-moderate hepatic impairment or mild-to moderate renal impairment (creatinine clearance > 30 mL/min). Elderly: No dose adjustment is normally required Paediatric population Experience with Lodoz in paediatric patients is limited, therefore its u Прочитајте комплетан документ